Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Saved in:
| Title: | Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. |
|---|---|
| Authors: | Barritt AS 4th; UNC Liver Center, University of North Carolina, Chapel Hill, North Carolina, USA., Tapper EB; University of Michigan, Ann Arbor, Michigan, USA., Newsome PN; Faculty of Life Sciences and Medicine, Roger Williams Institute of Liver Studies, King's College London and King's College Hospital, London, UK., Gazis D; Target RWE, Durham, North Carolina, USA., Morris H; Target RWE, Durham, North Carolina, USA., Mospan AR; Target RWE, Durham, North Carolina, USA., Perez AD; Target RWE, Durham, North Carolina, USA., Kim Y; Madrigal Pharmaceuticals, Inc., West Conshohocken, Pennsylvania, USA., Neuschwander-Tetri BA; Saint Louis University, St. Louis, Missouri, USA., Loomba R; University of California at San Diego, San Diego, California, USA., Sanyal A; Virginia Commonwealth University, Richmond, Virginia, USA . |
| Corporate Authors: | TARGET-NASH Investigators |
| Source: | The American journal of gastroenterology [Am J Gastroenterol] 2026 Mar 01; Vol. 121 (3), pp. 710-719. Date of Electronic Publication: 2025 Jun 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 0421030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1572-0241 (Electronic) Linking ISSN: 00029270 NLM ISO Abbreviation: Am J Gastroenterol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
